Ulrich Jäger (Ulrich Jaeger, Ulrich Jager)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine 30 (8) (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine (2024)
Marit Jalink, Chaja F Jacobs, Jahanzaib Khwaja, Dorothea Evers, Coty Bruggeman, Bruno Fattizzo, Marc Michel, Etienne Crickx, Quentin A A Hill, Ulrich Jäger, Arnon P Kater, Anja B U Mäkelburg, Anouk Breedijk, Peter A W Te Boekhorst, Marlijn P A Hoeks, Masja de Haas, Shirley D'Sa, Josephine M I M I Vos
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood advances 8 (11) (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine 30 (8) (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine (2024)
Marit Jalink, Chaja F Jacobs, Jahanzaib Khwaja, Dorothea Evers, Coty Bruggeman, Bruno Fattizzo, Marc Michel, Etienne Crickx, Quentin A A Hill, Ulrich Jäger, Arnon P Kater, Anja B U Mäkelburg, Anouk Breedijk, Peter A W Te Boekhorst, Marlijn P A Hoeks, Masja de Haas, Shirley D'Sa, Josephine M I M I Vos
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood advances 8 (11) (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine (2024)
Judith Trotman, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J Nastoupil
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study. Nature medicine 30 (8) (2024)
Marit Jalink, Chaja F Jacobs, Jahanzaib Khwaja, Dorothea Evers, Coty Bruggeman, Bruno Fattizzo, Marc Michel, Etienne Crickx, Quentin A A Hill, Ulrich Jäger, Arnon P Kater, Anja B U Mäkelburg, Anouk Breedijk, Peter A W Te Te Boekhorst, Marlijn P A Hoeks, Masja de de Haas, Shirley P D'Sa, Josephine M I M I Vos
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood advances (2024)
Marit Jalink, Chaja F Jacobs, Jahanzaib Khwaja, Dorothea Evers, Coty Bruggeman, Bruno Fattizzo, Marc Michel, Etienne Crickx, Quentin A A Hill, Ulrich Jäger, Arnon P Kater, Anja B U Mäkelburg, Anouk Breedijk, Peter A W Te Boekhorst, Marlijn P A Hoeks, Masja de Haas, Shirley P D'Sa, Josephine M I M I Vos
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood advances (2024)
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Cristina Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Giovanni Giovanni Carrabba, Christian Chabanon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Houot Roch, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermin M Sanchez-Guijo, Isabel Sánchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A Snowden, Catherine Thieblemont, Max S Topp, Pier Luigi Luigi Zinzani, John G Gribben, Chiara Bonini, Anna Sureda Balari, Ibrahim Yakoub Agha
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations. Blood (2023)
Stella Rosa Maria Wirth, Klaus Podar, Martin Pecherstorfer, Philipp Wohlfarth, Ulrich Jäger, Josef Singer
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination-A Retrospective Cohort Study. Cancers 15 (2) (2023)
Michael J Dickinson, Pere Barba, Ulrich Jäger, Nirav N Shah, Didier Blaise, Javier Briones, Leyla Shune, Nicolas Boissel, Attilio Bondanza, Luisa Mariconti, Anne-Laure Marchal, David S Quinn, Jennifer Yang, Andrew Price, Akash Sohoni, Louise M Treanor, Elena J Orlando, Jennifer Mataraza, Jaclyn Davis, Darlene Lu, Xu Zhu, Boris Engels, Laure Moutouh-de Parseval, Jennifer L Brogdon, Michele Moschetta, Ian W Flinn
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-Cell Stemness Shows Enhanced CAR T-Cell Efficacy in Preclinical and Early Clinical Development. Cancer discovery (2023)
Stella Rosa Maria Wirth, Klaus Podar, Martin Pecherstorfer, Philipp Wohlfarth, Ulrich Jäger, Josef Singer
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination-A Retrospective Cohort Study. Cancers 15 (2) (2023)
Adam J Olszewski, Tycel Jovelle Phillips, Marc S Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason R Westin, Izidore S Lossos, Javier L Muñoz, Jason Sit, Michael C Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L Yee, Ulrich Jäger
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood advances (2023)
Stephen M Ansell, Paul J Bröckelmann, Gottfried von Keudell, Jee Hun Lee, Armando Santoro, Pier Luigi Luigi Zinzani, Graham P Collins, Jonathon B Cohen, Jan Paul de Boer, John Kuruvilla, Kerry Joane Savage, Marek Trněný, Mariano Provencio, Ulrich Jäger, Wolfgang Willenbacher, Rachael Wen, Alev Akyol, Joanna Mikita-Geoffroy, Margaret A Shipp, Andreas Michael Engert, Philippe Armand
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study. Blood advances (2023)
Ulrich Jäger, Constantine S Tam, Peter Borchmann, Joseph P McGuirk, Marianne Johansen, Edmund K Waller, Samantha M Jaglowski, Charalambos Andreadis, Stephen R Foley, Jason R Westin, Isabelle Fleury, P Joy Ho, Stephan Mielke, Takanori Teshima, Gilles Andre Salles, Stephen J Schuster, Fiona He, Richard T Maziarz, Sebastian Mayer, Shinichi Makita, Marie J Kersten, Monalisa Ghosh, Nina D Wagner-Johnston, Koji Kato, Paolo Corradini, Hideki Goto, Silvia Colicino, Abhijit Agarwal, Chiara Lobetti-Bodoni, Michael R Bishop
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Blood advances 6 (16) (2022)
John Francis Seymour, Thomas J Kipps, Barbara F Eichhorst, James D'Rozario, Carolyn J Owen, Sarit Assouline, Nicole Lamanna, Tadeusz Robak, Javier de laSerna, Ulrich Jäger, Guillaume Cartron, Marco Montillo, Clemens Mellink, Brenda Chyla, Anesh Panchal, Tong Lu, Jenny Q Wu, Yanwen Jiang, Marcus Lefebure, Michelle Boyer, Arnon P Kater
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab. Blood 140 (8) (2022)
Karen Thudium Mueller, Stephan A Grupp, Shannon L Maude, John E Levine, Michael A Pulsipher, Michael W Boyer, Keith J August, G Doug Myers, Constantine S Tam, Ulrich Jäger, Stephen Ronan Foley, Peter Borchmann, Stephen J Schuster, Edmund K Waller, Rakesh Awasthi, Bernd Potthoff, Andy Warren, Edward R Waldron, Fraser McBlane, Andrea Chassot-Agostinho, Theodore W Laetsch
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Blood advances 5 (23) (2022)
Georg Gelbenegger, Ulrich Jäger, Michael Fillitz, Christian Schoergenhofer, Christian Sillaber, Bernd Jilma
Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease. Blood advances (2022)
Ulrich Jäger, Nina Worel, Joseph P McGuirk, Peter A Riedell, Isabelle Fleury, Yan Du, Xia Han, David Pearson, Santiago Redondo, Edmund K Waller
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: results from the phase Ib PORTIA study. Blood advances (2022)
Lorenz Schubert, Maximilian Koblischke, Lisa Schneider, Edit Porpaczy, Florian Winkler, Ulrich Jäger, Stephan Blüml, Helmuth Haslacher, Heinz Burgmann, Judith H Aberle, Stefan Winkler, Selma Tobudic
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers 14 (8) (2022)
Tim Heinemann, Christoph Kornauth, Yannik Severin, Gregory I Vladimer, Tea Pemovska, Emir Hadzijusufovic, Hermine Agis, Maria-Theresa Krauth, Wolfgang R Sperr, Peter Valent, Ulrich Jäger, Ingrid Simonitsch-Klupp, Giulio Superti-Furga, Philipp Bernhard Staber, Berend Snijder
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine. Blood cancer discovery 3 (6) (2022)
Sonali Sharma, Gabriela Mladonicka Pavlasova, Vaclav Seda, Katerina Amruz Cerna, Eva Vojackova, Daniel Filip, Laura Ondrisova, Veronika Sandova, Lenka Kostalova, Pedro F Zeni, Marek Borsky, Jan Oppelt, Kvetoslava Liskova, Leos Kren, Andrea Janikova, Sarka Pospisilova, Stacey M Fernandes, Medhat Shehata, Laura Z Rassenti, Ulrich Jäger, Michael Doubek, Matthew S Davids, Jennifer R Brown, Jiri Mayer, Thomas J Kipps, Marek Mraz
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. Blood 137 (18) (2021)
Edit Anna Porpaczy, Ulrich Jäger
Management of autoimmune complications in patients with lymphoid cancer. Blood (2021)
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Elmir Graf, Thomas Nösslinger, Michael Pfeilstöcker, Heinz Tüchler, Thamer Sliwa, Felix Keil, Christoph Geissler, Sonja Heibl, Josef Thaler, Sigrid Machherndl-Spandl, Otto Zach, Ansgar Weltermann, Peter Bettelheim, Reinhard Stauder, Armin Zebisch, Heinz Sill, Ilse Schwarzinger, Bruno Schneeweiss, Leopold Öhler, Ernst Ulsperger, Rajko Kusec, Ulrich Germing, Wolfgang R Sperr, Paul Knöbl, Ulrich Jäger, Gregor Hörmann, Peter Valent
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients. International journal of molecular sciences 21 (8) (2020)
Rainer Hubmann, Susanne Schnabl, Mohammad Araghi, Christian Schmidl, André F Rendeiro, Martin Hilgarth, Dita Demirtas, Farghaly Ali, Philipp B Staber, Peter Valent, Christoph Zielinski, Ulrich Jäger, Medhat Shehata
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. Cells 9 (6) (2020)
Marius E Mayerhoefer, Alexander R Haug, Ulrich Jäger, Verena Pichler, Sarah Pfaff, Hans-Jürgen Wester, Marcus Hacker, Lukas Kazianka, Philipp B Staber
In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer immunology research 8 (8) (2020)
Dominik Berzaczy, Alexander Haug, Philipp B Staber, Markus Raderer, Barbara Kiesewetter, Ulrich Jäger, Christoph Kornauth, Ingrid Simonitsch-Klupp, Marius E Mayerhoefer
RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients. Cancers 12 (1) (2019)
Philipp Bernhard Staber, Marco Herling, Mar Bellido, Eric D Jacobsen, Matthew S Davids, Tapan Mahendra Kadia, Andrei Shustov, Olivier Tournilhac, Emmanuel Bachy, Francesco Zaja, Kimmo Porkka, Gregor Hoermann, Ingrid Simonitsch-Klupp, Claudia Haferlach, Stefan Kubicek, Marius E Mayerhoefer, Georg Hopfinger, Ulrich Jäger, Claire Dearden
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood 134 (14) (2019)

Ulrich Jäger.css-eqlu8i{font-size:small;padding-left:4px;} (Ulrich Jaeger, Ulrich Jager)

Publication Activity (10 Years)

Top Topics

Top Venues

Ulrich Jäger (Ulrich Jaeger, Ulrich Jager)